Inhibition of MIP-1α-induced human neutrophil and monocyte chemotactic activity by reactive oxygen and nitrogen metabolites

Journal of Laboratory and Clinical Medicine

Volumn 135, Issue 2, 2000, Pages 161-169

  Sato, Etsuro ^a,b,c,d   Simpson, Keith L ^a,b,c,d   Grisham, Matthew B ^a,b,c,d   Koyama, Sekiya ^a,b,c,d   Robbins, Richard A ^a,b,c,d,e  

^a Research Service   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 MORPHOLINO SYDNONIMINE; 3-MORPHOLINO-SYDNONIMINE; COMPLEMENT; DEFEROXAMINE; DRUG DERIVATIVE; HYDRAZINE DERIVATIVE; LEUKOTRIENE B4; MACROPHAGE INFLAMMATORY PROTEIN 1; MOLSIDOMINE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; OXIDIZING AGENT; PAPA NONOATE; PEROXYNITRIC ACID;

ARTICLE; BLOOD; DRUG EFFECT; HUMAN; IN VITRO STUDY; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY;

CHEMOTAXIS, LEUKOCYTE; COMPLEMENT SYSTEM PROTEINS; DEFEROXAMINE; HUMANS; HYDRAZINES; LEUKOTRIENE B4; MACROPHAGE INFLAMMATORY PROTEIN-1; MOLSIDOMINE; MONOCYTES; NEUTROPHILS; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; OXIDANTS;

EID: 0034131539     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.104307     Document Type: Article

References (39)

1. 1. Wolpe SD, Davatelis G, Sherry B, et al. Macrophages secrete a novel heparin-binding protein with protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 1988;167:570-81.
2. 2. Wang JM, Sherry B, Fivash MJ, Kelvin DJ, Oppenheim J. Human recombinant macrophage inflammatory protein-1α and -β and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes. J Immunol 1993; 150:3022-9.
3. 3. Rot A, Kreiger M, Brunner S, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophilic granulocytes. J Exp Med 1992; 176:1489-95.
4. 4. Alam R, Forsythe PA, Stafford S, Lett-Brown MA, Grant JA. Macrophage inflammatory protein-1α induces the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992;176:781-6.
5. 5. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV. Human macrophage inflammatory protein α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J Exp Med 1993;177:1821-6.
6. 6. Mohammed KA, Nasreen N, Ward MJ, Antony VB. Macrophage inflammatory protein-1α C-C chemokine in parapneumonic pleural effusions. J Lab Clin Med 1998; 132: 202-9.
7. 7. Nakao M, Nomiyama H, Shimada K. Structures of human genes coding for cytokine LD78 and their expression. Mol Cell Biol 1990;10:3646-58.
8. 8. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydyls: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991;266:4244-50.
9. 9. Pryor WA, Jin X, Squadrito GL. One-and two-electron oxidations of methionine by peroxynitrite. Proc Natl Acad Sci U S A 1994:91:11173-7.
10. 10. Alvarez B, Rubbo H, Kirk M, Barnes S, Freeman BA, Radi R. Peroxynitrite-dependent tryptophan nitration. Chem Res Toxicol 1996;9:390-6.
11. 11. Ramezanian MS, Padmaja S, Koppenol WH. Nitration and cydroxylation of phenolic compounds by peroxynitrite. Chem Res Toxicol 1996;9:232-40.
12. 12. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996;9:836-44.
13. 13. McCall MN, Easterbrook-Smith SB. Comparison of the role of tyrosine residues in human IgG and rabbit IgG in binding complement subcomponent Clq. Biochem J 1989:257:845-51.
14. 14. Gow AJ, Duran D, Malcolm S, Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett 1996;385:63-6.
15. 15. Yamakura F, Taka H, Fujimura T, Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998;273:14085-9.
16. 16. Böyum A. Isolation of mononuclear cells and granulocvtes from human blood. Scand J Clin Lab Invest 1968;97: 77-89.
17. 17. Harvath L, Falk W, Leonard EJ. Rapid quanitification of neutrophil chemotaxis: use of polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly. J Immunol Methods 1980;37:39-45.
18. 18. Snyderman R, Gewurz H, Mergenhagen SE. Interactions of the complement system with endotoxic lipopolysaccharide: generation of a factor chemotactic for polymorphonuclear leukocytes. J Exp Med 1968; 128:259-75.
19. 19. Wink DA, Cook JA, Christodoulou D, et al. Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. Nitric Oxide 1997; 1:88-94.
20. 20. Keefer LK, Nims RW, Davies KM, Wink DA. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 1996;268:281-93.
21. 21. Fridovich I. Quantitative aspects of the production of super-oxide anion radical by milk xanthine oxidase. J Biol Chem 1970;245:4053-7.
22. 22. Jones KL, Bryan TW, Jinkins PA, et al. Superoxide released from neutrophils cause a reduction in nitric oxide gas. Am J Physiol 1998;275:L1120-6.
23. 23. Holm P, Kankaanranta H, Metsa-Ketela T, Moilanen E. Rad-ical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine. Eur JPharma-col 1998;346:97-102.
24. 24. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S. The simultaneous generation of Superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun 1992; 17:9-20.
25. 25. Bath PM. The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro. Eur J Clin Pharmacol 1993;45:53-8.
26. 26. Moilanen E, Vuorinen P, Kankaanranta H, Metsa-Ketela T, Vapaatalo H. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br J Pharmacol 1993;109:852-8.
27. 27. Kaplan SS, Billiar T, Curran RD, Zdziarski UE, Simmons RL, Basford RE. Attenuation of chemotaxis with NG-monomethyl-L-arginine: a role for cyclic GMP. Blood 1989;74:1885-7.
28. 28. Belenky SN, Robbins RA, Rennard SI, Gossman GL, Nelson KJ, Rubinstein I. Inhibitors of nitric oxide synthase attenuate neutrophil chemotaxis in vitro. J Lab Clin Med 1993; 122:388-94.
29. 29. Belenky SN, Robbins RA, Rubinstein I. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukocyte Biol 1993;53:498-503.
30. 30. Davatelis G, Tekamp-Olson P, Wolpe SD, et al. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. J Exp Med 1988;167:1939-44.
31. 31. Kasama T, Strieter RM, Lukacs NM, Lincoln PM, Burdick MD, Kunkel SL. Interleukin 10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 1995;95:2868-76.
32. 32. McColl SR, Hachicha M, Levasseur S, Neote K, Schall TJ. Uncoupling of early signal transduction events from effector function in human peripheral blood neutrophils in response to recombinant macrophage inflammatory proteins-1 alpha and -1 beta. J Immunol 1993;150:4550-60.
33. 33. Zhang S, Youn BS, Gao JL, Murphy PM, Kwon BS. Differential effects of leukotactin-1 and macrophage inflammatory protein-1 alpha on neutrophils mediated by CCRI. J Immunol 1999;4938-42.
34. 34. Standiford TJ, Rolfe MW, Kunkel SL, et al. Macrophage inflammatory protein-1 expression in interstitial lung disease. J Immunol 1993;151:2852-63.
35. 35. Rohn TT, Quinn MT. Inhibition of peroxynitrite-mediated tyrosine nitration by a novel pyrrolopyrimidine antioxidant. Eur J Pharmacol 1998;353:329-36.
36. 36. Denicola A, Souza JM, Gatti RM, Augusto O, Radi R. Desferrioxamine inhibition of the hydroxyl radical-like reactivity of peroxynitrite: role of the hydroxamic groups. Free Radic Biol Med 1995;19:11-9.
37. 37. Schraufstatter IU, Ma M, Oades ZG, Barritt DS, Cochrane CG. The role of Tyr13 and Lys15 of interleukin-8 in the high affinity interaction with the interleukin-8 receptor type A. J Biol Chem 1995;270:10428-31.
38. 38. Steitz SA, Hasegawa H, Chiang SL, et al. Mapping of MCP-1 functional domains by peptide analysis and site-directed mutagenesis. FEBS Lett 1998;430:158-64.
39. 39. Vogt W. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic Biol Med 1995;18:93-105. (J Lab Clin Med 2000; 135:170-3)